Cultural Corner
Advertisement
Advertisement
Trending on Psychiatric Times
1
Remlifanserin for the Treatment of Alzheimer Disease Psychosis Receives FDA Fast Track Designation
2
Future DSM Plans Overlook Core Problem of Validity
3
Targeting APOE4: A Promising Therapeutic Strategy for Alzheimer Disease
4
Classic Drug, New Target: Lithium as Disease-Modifying in Alzheimer Dementia
5
